Search research articles
Contact Us
Filters
Showing results (421-430 of 1,676) with videos related to
Page
of 168
Sort By:
Circulation. Heart Failure
|
June 23, 2016
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I)
Ted Feldman, Jan Komtebedde, Daniel Burkhoff, et al.
Circulation. Heart Failure
|
June 16, 2016
Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry
Kristin E Bergethon, Christine Ju, Adam D DeVore, et al.
Circulation. Heart Failure
|
October 18, 2013
Predictors of disease progression in pediatric dilated cardiomyopathy
Kimberly M Molina, Peter Shrader, Steven D Colan, et al.
Circulation. Heart Failure
|
October 17, 2013
Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals
Naoki Fujimoto, Jeffrey L Hastings, Graeme Carrick-Ranson, et al.
Circulation. Heart Failure
|
November 12, 2013
Prevalence and prognostic importance of changes in renal function after mechanical circulatory support
Meredith A Brisco, Stephen E Kimmel, Steven G Coca, et al.
Circulation. Heart Failure
|
November 17, 2011
Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices
Jorge Suarez, Chetan B Patel, G Michael Felker, et al.
Circulation. Heart Failure
|
March 30, 2012
Plasticity of surface structures and β(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure
Alexander R Lyon, Viacheslav O Nikolaev, Michele Miragoli, et al.
Circulation. Heart Failure
|
June 5, 2012
Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution
Loren E Wold, Zhekang Ying, Kirk R Hutchinson, et al.
Circulation. Heart Failure
|
May 26, 2012
Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure
Hanako Morooka, Yoshitaka Iwanaga, Yodo Tamaki, et al.
Circulation. Heart Failure
|
September 17, 2015
Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials
G Michael Felker, Robert J Mentz, Kirkwood F Adams, et al.
Page
of 168
Search research articles
Search
Showing results (421-430 of 1,676) with videos related to
Sort By:
Page
of 168
Circulation. Heart Failure
|
June 23, 2016
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I)
Ted Feldman, Jan Komtebedde, Daniel Burkhoff, et al.
Circulation. Heart Failure
|
June 16, 2016
Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry
Kristin E Bergethon, Christine Ju, Adam D DeVore, et al.
Circulation. Heart Failure
|
October 18, 2013
Predictors of disease progression in pediatric dilated cardiomyopathy
Kimberly M Molina, Peter Shrader, Steven D Colan, et al.
Circulation. Heart Failure
|
October 17, 2013
Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals
Naoki Fujimoto, Jeffrey L Hastings, Graeme Carrick-Ranson, et al.
Circulation. Heart Failure
|
November 12, 2013
Prevalence and prognostic importance of changes in renal function after mechanical circulatory support
Meredith A Brisco, Stephen E Kimmel, Steven G Coca, et al.
Circulation. Heart Failure
|
November 17, 2011
Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices
Jorge Suarez, Chetan B Patel, G Michael Felker, et al.
Circulation. Heart Failure
|
March 30, 2012
Plasticity of surface structures and β(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure
Alexander R Lyon, Viacheslav O Nikolaev, Michele Miragoli, et al.
Circulation. Heart Failure
|
June 5, 2012
Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution
Loren E Wold, Zhekang Ying, Kirk R Hutchinson, et al.
Circulation. Heart Failure
|
May 26, 2012
Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure
Hanako Morooka, Yoshitaka Iwanaga, Yodo Tamaki, et al.
Circulation. Heart Failure
|
September 17, 2015
Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials
G Michael Felker, Robert J Mentz, Kirkwood F Adams, et al.
Page
of 168